PLCB1 and breast cancer: Depletion of PTPRN2 or PLCβ1 in MDA‐MB‐468 and CNLM1a1 breast cancer cells also significantly increased plasma membrane PI(4,5)P2 levels (Appendix Fig S3C and D).